Abstract
WHEN IT COMES to attempts to assess and evaluate the effectiveness of unconventional methods of treating cancer, there appears to be no meeting of minds, whether the subject be a particular treatment or the methods of assessing it. The latest attempt, a massive 3-year effort by the Office of Technology Assessment (OTA), seems doomed even before it appears in print. Better no report at all than this draft, Frank D. Wiewel of People Against Cancer told an OTA advisory panel at an unusual public hearing on the report. Wiewel was one of a group who pushed Congress into getting the OTA to take a look at alternative cancer therapies. Now he says he's sorry he made the effort. Although Wiewel was one of the more vociferous critics of the draft, even relatively quiet-spoken academicians, such as campus historian Patricia Spain Ward of the University of Illinois at Chicago Circle, told
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
